title: The ten studies that should be done in ARDS.
authors.affiliation: Department of Critical Care Medicine, Flinders University, Bedford Park, Adelaide, SA, Australia.|Department of Intensive Care Medicine, Flinders Medical Centre, Bedford Park, Adelaide, SA, Australia.
authors.forename: Shailesh
authors.initials: S
authors.lastname: Bihari
authors.affiliation: Department of Anesthesia, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada.|Department of Anesthesia and Physiology, University of Toronto, Toronto, Ontario, Canada.
authors.forename: John G
authors.initials: JG
authors.lastname: Laffey
authors.affiliation: Department of Critical Care Medicine, Flinders University, Bedford Park, Adelaide, SA, Australia. andrew.bersten@flinders.edu.au.|Department of Intensive Care Medicine, Flinders Medical Centre, Bedford Park, Adelaide, SA, Australia. andrew.bersten@flinders.edu.au.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Bersten
mesh_terms: D035843:Biomedical Research; D002986:Clinical Trials as Topic; D005440:Fluid Therapy / Q000639:trends; D006801:Humans; D006935:Hypercapnia / Q000517:prevention & control; D010102:Oxygen Inhalation Therapy / Q000639:trends; D010641:Phenotype; D042787:Receptor, TIE-2 / Q000819:agonists; D012121:Respiration, Artificial / Q000639:trends; D012128:Respiratory Distress Syndrome / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000639:trends; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors
chemical_list: D050916:TRPV Cation Channels; C416986:TRPV4 protein, human; D042787:Receptor, TIE-2